Balaji Gandhi Sells 28,759 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 28,759 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $30.00, for a total transaction of $862,770.00. Following the transaction, the chief financial officer now directly owns 116,174 shares in the company, valued at $3,485,220. This trade represents a 19.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Stock Performance

Shares of PHR stock traded up $0.15 during trading hours on Tuesday, hitting $29.99. 409,526 shares of the company were exchanged, compared to its average volume of 382,504. The firm has a fifty day simple moving average of $26.93 and a 200 day simple moving average of $23.68. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of -20.40 and a beta of 0.96.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter last year, the business posted ($0.58) EPS. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. Research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several large investors have recently modified their holdings of the stock. Johnson Financial Group Inc. grew its stake in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after buying an additional 896 shares in the last quarter. R Squared Ltd purchased a new position in Phreesia in the 4th quarter valued at approximately $30,000. BankPlus Trust Department purchased a new position in Phreesia in the 4th quarter valued at approximately $34,000. International Assets Investment Management LLC grew its stake in Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares in the last quarter. Finally, Quarry LP grew its stake in Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after buying an additional 1,923 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on PHR shares. Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Piper Sandler reiterated an “overweight” rating and issued a $33.00 price objective (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Friday, January 10th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia has an average rating of “Buy” and a consensus target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.